Cargando…
MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo
ARF couples with TP53 in a canonical signaling pathway to activate cellular senescence for tumor suppressive function under oncogenic insults. However, the mechanisms on aberrant elevation of ARF in cancers are still poorly understood. We previously showed that ARF (p14(ARF) in human and p19(Arf) in...
Autores principales: | Xie, Yingqiu, Lu, Wenfu, Liu, Shenji, Yang, Qing, Goodwin, J. Shawn, Sathyanarayana, Sandeep Anantha, Pratap, Siddharth, Chen, Zhenbang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216965/ https://www.ncbi.nlm.nih.gov/pubmed/27356744 http://dx.doi.org/10.18632/oncotarget.10251 |
Ejemplares similares
-
Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phosphor-Tyrosine in prostate cancer
por: Xie, Yingqiu, et al.
Publicado: (2018) -
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination
por: Lu, Wenfu, et al.
Publicado: (2014) -
Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications
por: Chen, Zhenbang, et al.
Publicado: (2015) -
Dysregulation of YAP by ARF Stimulated with Tea-derived Carbon Nanodots
por: Xie, Yingqiu, et al.
Publicado: (2017) -
Heteronemin Suppresses Lymphangiogenesis through ARF-1 and MMP-9/VE-Cadherin/Vimentin
por: Chen, Hsien-Lin, et al.
Publicado: (2021)